Exelixis, Inc.
Exelixis, Inc. Fundamental Analysis
Exelixis, Inc. (EX9.DE) shows strong financial fundamentals with a PE ratio of 19.80, profit margin of 28.44%, and ROE of 22.44%. The company generates $1.6B in annual revenue with strong year-over-year growth of 18.49%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 85.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze EX9.DE's fundamental strength across five key dimensions:
Efficiency Score
ExcellentEX9.DE demonstrates superior asset utilization.
Valuation Score
ExcellentEX9.DE trades at attractive valuation levels.
Growth Score
ModerateEX9.DE shows steady but slowing expansion.
Financial Health Score
ExcellentEX9.DE maintains a strong and stable balance sheet.
Profitability Score
ExcellentEX9.DE achieves industry-leading margins.
Key Financial Metrics
Is EX9.DE Expensive or Cheap?
P/E Ratio
EX9.DE trades at 19.80 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, EX9.DE's PEG of -2.19 indicates potential undervaluation.
Price to Book
The market values Exelixis, Inc. at 5.10 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 16.07 times EBITDA. This signals the market has high growth expectations.
How Well Does EX9.DE Make Money?
Net Profit Margin
For every $100 in sales, Exelixis, Inc. keeps $28.44 as profit after all expenses.
Operating Margin
Core operations generate 33.10 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $22.44 in profit for every $100 of shareholder equity.
ROA
Exelixis, Inc. generates $19.54 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Exelixis, Inc. generates strong operating cash flow of $499.48M, reflecting robust business health.
Free Cash Flow
Exelixis, Inc. generates strong free cash flow of $489.94M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $1.72 in free cash annually.
FCF Yield
EX9.DE converts 5.08% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
19.80
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.19
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.10
vs 25 benchmark
P/S Ratio
Price to sales ratio
5.89
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.09
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.51
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.22
vs 25 benchmark
ROA
Return on assets percentage
0.20
vs 25 benchmark
ROCE
Return on capital employed
0.26
vs 25 benchmark
How EX9.DE Stacks Against Its Sector Peers
| Metric | EX9.DE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 19.80 | 28.54 | Better (Cheaper) |
| ROE | 22.44% | 738.00% | Weak |
| Net Margin | 28.44% | -43982.00% (disorted) | Strong |
| Debt/Equity | 0.09 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 3.51 | 2806.01 | Strong Liquidity |
| ROA | 19.54% | -14624.00% (disorted) | Strong |
EX9.DE outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Exelixis, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
133.79%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
69.41%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
38.58%
Industry Style: Defensive, Growth, Innovation
High Growth